254 filings
Page 8 of 13
8-K
zyowr63i2trdwhu 5y1
6 Nov 18
Cara Therapeutics Reports Third Quarter 2018 Financial Results
4:11pm
8-K
052n f2humsy34
23 Oct 18
Departure of Directors or Certain Officers
7:29am
CT ORDER
jb6ksk 9v5q
11 Sep 18
Confidential treatment order
12:00am
8-K
a9crcc22aih17jojk
7 Aug 18
Cara Therapeutics Reports Second Quarter 2018 Financial Results
4:11pm
8-K
k3qfz8ayevffvxw0l
6 Aug 18
Departure of Directors or Certain Officers
4:10pm
8-K
s2ighf
23 Jul 18
Cara Therapeutics Announces Pricing of $85.5 Million Offering of Common Stock
4:10pm
424B5
byn0mxfntf 0go32wu9s
20 Jul 18
Prospectus supplement for primary offering
4:12pm
8-K
65ld0663
17 Jul 18
Cara Therapeutics Announces Proposed Offering of Common Stock
5:24pm
424B5
azstjb wzelow
17 Jul 18
Prospectus supplement for primary offering
5:23pm
8-K
e0j p341x
27 Jun 18
Cara Therapeutics Reports PositiveTop-Line Data from Adaptive Phase 2/3 Trial of I.V. CR845 in Patients Undergoing Abdominal Surgery
4:06pm
8-K
zsa9crr lljn
8 Jun 18
Submission of Matters to a Vote of Security Holders
4:04pm
8-K
fzs9jj8
23 May 18
Cara receives upfront payment of $50 million in cash and an equity investment of $20 million
8:30am
8-K
1f12 cx1k
23 May 18
Entry into a Material Definitive Agreement
6:06am
8-K
iu50sn4g
9 May 18
Cara Therapeutics Reports First Quarter 2018 Financial Results
4:10pm
DEFA14A
ucq4s08auxdlno8
26 Apr 18
Additional proxy soliciting materials
4:16pm
S-8
tjf9mu
16 Mar 18
Registration of securities for employees
12:00am